Wird geladen...
Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives
Type 1 diabetes (T1D) is caused by autoimmune destruction of insulin-producing β cells located in the endocrine pancreas in areas known as islets of Langerhans. The current standard-of-care for T1D is exogenous insulin replacement therapy. Recent developments in this field include the hybrid closed-...
Gespeichert in:
| Veröffentlicht in: | Clin Med Insights Endocrinol Diabetes |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501476/ https://ncbi.nlm.nih.gov/pubmed/31105434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551419844521 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|